Globus Medical (NYSE: GMED) reported Q4 EPS of $0.59, $0.03 better than the analyst estimate of $0.56. Revenue for the quarter came in at $274.5 million versus the consensus estimate of $276.85 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.